Clinical and molecular findings in a cohort of <i>ANO5</i>‐related myopathy

Abstract

We present the largest series of anoctaminopathy outside Europe. The most common European founder mutation c.191dupA was very frequent in our population. Gender, disease duration, and genotype did not determine the phenotype.